TTM
$8.50
YoY change
+90.5%
5Y CAGR
+14.9%
Peak year (2023)
$13.72
Latest annual
$11.03
EPS (Diluted) history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: $11.03
EPS (Diluted) growth chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: +90.5%
EPS (Diluted) history table for Johnson & Johnson (JNJ) from 1985 to 2025
| 2025 | $11.03 | +90.5% | +$5.24 | ||
| 2024 | $5.79 | -57.8% | −$7.93 | ||
| 2023 | $13.72 | +103.9% | +$6.99 | ||
| 2022 | $6.73 | -13.8% | −$1.08 | ||
| 2021 | $7.81 | +41.7% | +$2.30 | ||
| 2020 | $5.51 | -2.1% | −$0.12 | ||
| 2019 | $5.63 | +0.4% | +$0.02 | ||
| 2018 | $5.61 | +1093.6% | +$5.14 | ||
| 2017 | $0.47 | -92.1% | −$5.46 | ||
| 2016 | $5.93 | +8.2% | +$0.45 | ||
| 2015 | $5.48 | -3.9% | −$0.22 | ||
| 2014 | $5.70 | +18.5% | +$0.89 | ||
| 2013 | $4.81 | +24.6% | +$0.95 | ||
| 2012 | $3.86 | +10.6% | +$0.37 | ||
| 2011 | $3.49 | -27.0% | −$1.29 | ||
| 2010 | $4.78 | +8.6% | +$0.38 | ||
| 2009 | $4.40 | -3.7% | −$0.17 | ||
| 2008 | $4.57 | +25.9% | +$0.94 | ||
| 2007 | $3.63 | -2.7% | −$0.10 | ||
| 2006 | $3.73 | +11.3% | +$0.38 | ||
| 2005 | $3.35 | +22.3% | +$0.61 | ||
| 2004 | $2.74 | +19.7% | +$0.45 | ||
| 2003 | $2.29 | +6.0% | +$0.13 | ||
| 2002 | $2.16 | +17.4% | +$0.32 | ||
| 2001 | $1.84 | +14.3% | +$0.23 | ||
| 2000 | $1.61 | +15.8% | +$0.22 | ||
| 1999 | $1.39 | +31.1% | +$0.33 | ||
| 1998 | $1.06 | -12.4% | −$0.15 | ||
| 1997 | $1.21 | +11.0% | +$0.12 | ||
| 1996 | $1.09 | +17.2% | +$0.16 | ||
| 1995 | $0.93 | +19.2% | +$0.15 | ||
| 1994 | $0.78 | +14.7% | +$0.10 | ||
| 1993 | $0.68 | +325.0% | +$0.52 | ||
| 1992 | $0.16 | -70.4% | −$0.38 | ||
| 1991 | $0.54 | +25.6% | +$0.11 | ||
| 1990 | $0.43 | +7.5% | +$0.03 | ||
| 1989 | $0.40 | +14.3% | +$0.05 | ||
| 1988 | $0.35 | +12.9% | +$0.04 | ||
| 1987 | $0.31 | +158.3% | +$0.19 | ||
| 1986 | $0.12 | -42.9% | −$0.09 | ||
| 1985 | $0.21 | — | — |
- 2025$11.03+90.5%
- 2024$5.79-57.8%
- 2023$13.72+103.9%
- 2022$6.73-13.8%
- 2021$7.81+41.7%
- 2020$5.51-2.1%
- 2019$5.63+0.4%
- 2018$5.61+1093.6%
- 2017$0.47-92.1%
- 2016$5.93+8.2%
- 2015$5.48-3.9%
- 2014$5.70+18.5%
- 2013$4.81+24.6%
- 2012$3.86+10.6%
- 2011$3.49-27.0%
- 2010$4.78+8.6%
- 2009$4.40-3.7%
- 2008$4.57+25.9%
- 2007$3.63-2.7%
- 2006$3.73+11.3%
- 2005$3.35+22.3%
- 2004$2.74+19.7%
- 2003$2.29+6.0%
- 2002$2.16+17.4%
- 2001$1.84+14.3%
- 2000$1.61+15.8%
- 1999$1.39+31.1%
- 1998$1.06-12.4%
- 1997$1.21+11.0%
- 1996$1.09+17.2%
- 1995$0.93+19.2%
- 1994$0.78+14.7%
- 1993$0.68+325.0%
- 1992$0.16-70.4%
- 1991$0.54+25.6%
- 1990$0.43+7.5%
- 1989$0.40+14.3%
- 1988$0.35+12.9%
- 1987$0.31+158.3%
- 1986$0.12-42.9%
- 1985$0.21—
EPS (Diluted) values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current diluted EPS (TTM) is $8.50. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Johnson & Johnson (JNJ) diluted EPS is $11.03 – surged 90.5% year-over-year.
Over 2020–2025 (5 years), Johnson & Johnson diluted EPS expanded at a +14.9% compound annual rate, with mixed annual results across the window.
Johnson & Johnson diluted EPS declined from $13.72 in 2023 to $11.03 in 2025, a 19.6% drawdown.
2023 marks the peak diluted EPS at $13.72, with the historical low of $0.12 recorded in 1986.
Johnson & Johnson EPS (Diluted) by Year
Johnson & Johnson EPS (Diluted) 2025: $11.03
In 2025, Johnson & Johnson reported diluted EPS of $11.03, surged 90.5% from 2024.
Johnson & Johnson EPS (Diluted) 2024: $5.79
Johnson & Johnson diluted EPS in 2024 was $5.79, plunged 57.8% below 2023.
Johnson & Johnson EPS (Diluted) 2023: $13.72
2023's diluted EPS for Johnson & Johnson came in at $13.72, surged 103.9% from 2022. This figure represents the highest annual value in the available history.
Johnson & Johnson EPS (Diluted) 2022: $6.73
Johnson & Johnson posted diluted EPS of $6.73 in 2022, declined 13.8% below 2021.
Johnson & Johnson EPS (Diluted) 2021: $7.81
Johnson & Johnson diluted EPS in 2021 was $7.81.
See more financial history for Johnson & Johnson (JNJ). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest diluted EPS
| $22.95 | |
| $17.74 | |
| $14.23 | |
| $13.23 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation